“Risk Analysis of AST and ALT Level in Patients With Diabetes Mellitus Type 2”. Jaringan Laboratorium Medis, vol. 4, no. 1, Dec. 2023, pp. 51-55, https://doi.org/10.31983/jlm.v4i1.8489.